Efficacy of Trastuzumab-Based Therapy After Disease Progression on Lapatinib Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer Patients

Simple item page
dc.contributor.authorUncu, Dogan
dc.contributor.authorBayoglu, Ibrahim Vedat
dc.contributor.authorArslan, Ulku Yalcintas
dc.contributor.authorKucukoner, Mehmet
dc.contributor.authorArtac, Mehmet
dc.contributor.authorKoca, Dogan
dc.contributor.authorOguz, Arzu
dc.contributor.authorDemirci, Umut
dc.contributor.authorArpaci, Erkan
dc.contributor.authorDogan, Mutlu
dc.contributor.orcIDhttps://orcid.org/0000-0001-6512-6534en_US
dc.contributor.researcherIDW-8004-2019en_US
dc.date.accessioned2024-03-06T12:55:29Z
dc.date.available2024-03-06T12:55:29Z
dc.date.issued2014
dc.identifier.issn0732-183Xen_US
dc.identifier.issue15en_US
dc.identifier.urihttp://hdl.handle.net/11727/11728
dc.identifier.volume32en_US
dc.identifier.wos000358613200080en_US
dc.language.isoengen_US
dc.relation.isversionof10.1200/jco.2014.32.15_suppl.e11586en_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEfficacy of Trastuzumab-Based Therapy After Disease Progression on Lapatinib Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer Patientsen_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine